患者登録ソフトウェアの世界市場：2023-2030年

世界の患者登録ソフトウェア市場は、予測期間（2023-2030年）にCAGR 8.6％で成長すると予測されます。市場の成長は、世界中の患者中心のケアに起因しています。患者擁護団体の参加に加え、患者報告による転帰測定が含まれることは、患者中心のケアへの傾向の高まりを反映しています。この移行は、患者の視点や経験を記録する患者登録ソフトウェアによって支援されています。米国国立衛生研究所によると、2023年5月現在、患者登録は欧州を中心に幅広い疾患領域をカバーしています。92％の登録が臨床患者を含み、81％がインフォームドコンセントを取得し、76％が収集したデータを保護しました。57％のレジストリが患者報告アウトカム指標を収集し、38％がレジストリの設計プロセス中にPAGと協議し、51％が品質管理の詳細を報告し、46％が維持管理の詳細を報告しました。

セグメント別の展望

疾患別レジストリのサブセグメントが世界の患者登録ソフトウェア市場でかなりのシェアを占めると予想されます。

レジストリの種類の中では、疾患別レジストリのサブセグメントが世界の患者登録ソフトウェア市場でかなりのシェアを占めると予想されます。BMCによると、2022年4月、疾患レジストリシステムは、同じ疾患を持つ患者の特定の集団に関するデータを収集、分析、報告するために使用される情報システムです。ヘルスケアの評価、罹患率や有病率の推定、ケアの質のモニタリング、フィードバックの提供、疾患の自然経過の観察、臨床安全性のモニタリング、疾患負担、健康アウトカム、コストの評価に使用できます。

地域別展望

患者登録ソフトウェアの世界市場は、北米（米国、カナダ）、欧州（英国、イタリア、スペイン、ドイツ、フランス、その他欧州地域）、アジア太平洋地域（インド、中国、日本、韓国、その他アジア地域）、世界のその他の地域（中東とアフリカ、ラテンアメリカ）を含む地域別にさらに細分化されます。なかでも北米は、慢性疾患の有病率が高いことに加え、同地域で実施される治療手術の件数が増加していることから、世界全体で大きなシェアを占めると予想されます。

欧州地域は、世界の患者登録ソフトウェア市場で大きなCAGRで成長すると予想される

全地域の中で、欧州地域は予測期間中にかなりのCAGRで成長すると予測されています。同地域の成長は、同地域における希少疾患のアドボカシーの高まりに起因しています。希少疾患のアドボカシーと認知に重点が置かれるようになったことで、希少疾患に苦しむ患者の満たされていない医療要件が浮き彫りになってきました。患者登録は、患者の経験に関する実際のデータを収集することにより、これらの目的を達成するのに役立ちます。Frontiers誌によると、2022年8月、欧州医薬品庁（EMA）が審査した販売承認申請の26.8％は、いわゆる希少疾病用医薬品でした。希少疾病用医薬品は、生命を脅かすか慢性的に衰弱させるが、欧州連合（EU）における有病率が1万人に5人未満である疾病の治療、予防、診断の促進を目的としたものです。これらの医薬品は、患者集団が小規模で不均一であるため、臨床エビデンスが限られていることが多く、患者登録はこの課題に対処し、規制当局の意思決定を支援するデータを提供する潜在的な方法として認識されています。患者登録は、特定の疾患、状態、または曝露を有する集団の特定の健康転帰に関するデータを収集し、整理する組織化されたシステムです。

目次

第1章 レポート概要

• 業界の現状分析と成長ポテンシャルの展望
• 調査方法とツール
• 市場内訳
  • セグメント別
  • 地域別

第2章 市場概要と洞察

• 調査範囲
• アナリストの洞察と現在の市場動向
  • 主な調査結果
  • 推奨事項
  • 結論

第3章 競合情勢

• 主要企業分析
• Apixo, Inc.
  • 概要
  • 財務分析
  • SWOT分析
  • 最近の動向
• ArborMetrix
  • 会社概要
  • 財務分析
  • SWOT分析
  • 最近の動向
• Cerner Corp.
  • 概要
  • 財務分析
  • SWOT分析
  • 最近の動向
• 主要戦略分析

第4章 市場セグメンテーション

• 患者登録ソフトウェアの世界市場：レジストリタイプ別
  • 疾患別レジストリ
  • 医療サービスレジストリ
  • 製品レジストリ
• 患者登録ソフトウェアの世界市場：ソフトウェアタイプ別
  • スタンドアロン型ソフトウェア
  • 統合ソフトウェア
• 患者登録ソフトウェアの世界市場：展開別
  • オンプレミス
  • クラウド
• 患者登録ソフトウェアの世界市場：エンドユーザー別
  • 病院および医療システム
  • 政府機関および第三者機関（TPA）
  • 製薬、バイオテクノロジー、医療機器企業
  • その他（学術・調査機関、医療保険事業者）

第5章 地域別分析

• 北米
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • イタリア
  • スペイン
  • フランス
  • その他欧州
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• 世界のその他の地域

第6章 企業プロファイル

• Dacima Software, Inc.
• DSG, Inc.
• FIGmd Inc.
• Global Vision TechnologiesImage Trend Inc.
• Health Catalyst
• IBM Corp.
• IQVIA Inc.
• Liaison Technology Group
• McKesson Corp.
• Open Text Corp.
• Optum, Inc.
• Ordinal Data, Inc.
• Syneos Health
• Velos Inc.

LIST OF TABLES

• 1. GLOBAL PATIENT REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY TYPE OF REGISTRY, 2022-2030 ($ MILLION)
• 2. GLOBAL DISEASE-SPECIFIC PATIENT REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 3. GLOBAL HEALTH SERVICE PATIENT REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 4. GLOBAL PRODUCT PATIENT REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 5. GLOBAL PATIENT REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY TYPE OF SOFTWARE, 2022-2030 ($ MILLION)
• 6. GLOBAL STAND-ALONE SOFTWARE PATIENT REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 7. GLOBAL INTEGRATED SOFTWARE PATIENT REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 8. GLOBAL PATIENT REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY DEPLOYMENT, 2022-2030 ($ MILLION)
• 9. GLOBAL PATIENT REGISTRY SOFTWARE BASED ON-PREMISES RESEARCH MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 10. GLOBAL PATIENT REGISTRY SOFTWARE BASED ON CLOUD REVIEW AND MANAGEMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 11. GLOBAL PATIENT REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
• 12. GLOBAL PATIENT REGISTRY SOFTWARE FOR HOSPITALS AND HEALTH SYSTEMS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 13. GLOBAL PATIENT REGISTRY SOFTWARE FOR GOVERNMENT ORGANIZATIONS AND THIRD PARTY ADMINISTRATORS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 14. GLOBAL PATIENT REGISTRY SOFTWARE FOR PHARMACEUTICAL, BIOTECHNOLOGY, AND MEDICAL DEVICE COMPANIES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 15. GLOBAL PATIENT REGISTRY SOFTWARE FOR OTHER END-USERS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 16. GLOBAL PATIENT REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 17. NORTH AMERICAN PATIENT REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
• 18. NORTH AMERICAN PATIENT REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY TYPE OF REGISTRY, 2022-2030 ($ MILLION)
• 19. NORTH AMERICAN PATIENT REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY TYPE OF SOFTWARE, 2022-2030 ($ MILLION)
• 20. NORTH AMERICAN PATIENT REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY DEPLOYMENT , 2022-2030 ($ MILLION)
• 21. NORTH AMERICAN PATIENT REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
• 22. EUROPEAN PATIENT REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
• 23. EUROPEAN PATIENT REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY TYPE OF REGISTRY, 2022-2030 ($ MILLION)
• 24. EUROPEAN PATIENT REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY TYPE OF SOFTWARE, 2022-2030 ($ MILLION)
• 25. EUROPEAN PATIENT REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY DEPLOYMENT, 2022-2030 ($ MILLION)
• 26. EUROPEAN PATIENT REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
• 27. ASIA-PACIFIC PATIENT REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
• 28. ASIA-PACIFIC PATIENT REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY TYPE OF REGISTRY , 2022-2030 ($ MILLION)
• 29. ASIA-PACIFIC PATIENT REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY TYPE OF SOFTWARE, 2022-2030 ($ MILLION)
• 30. ASIA-PACIFIC PATIENT REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY DEPLOYMENT, 2022-2030 ($ MILLION)
• 31. ASIA-PACIFIC PATIENT REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
• 32. REST OF THE WORLD PATIENT REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 33. REST OF THE WORLD PATIENT REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY TYPE OF REGISTRY , 2022-2030 ($ MILLION)
• 34. REST OF THE WORLD PATIENT REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY TYPE OF SOFTWARE, 2022-2030 ($ MILLION)
• 35. REST OF THE WORLD PATIENT REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY DEPLOYMENT , 2022-2030 ($ MILLION)
• 36. REST OF THE WORLD PATIENT REGISTRY SOFTWARE MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)

LIST OF FIGURES

• 1. GLOBAL PATIENT REGISTRY SOFTWARE MARKET SHARE BY TYPE OF REGISTRY, 2022 VS 2030 (%)
• 2. GLOBAL DISEASE-SPECIFIC PATIENT REGISTRY SOFTWARE MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 3. GLOBAL HEALTH SERVICE PATIENT REGISTRY SOFTWARE MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 4. GLOBAL PRODUCT PATIENT REGISTRY SOFTWARE MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 5. GLOBAL PATIENT REGISTRY SOFTWARE MARKET SHARE BY TYPE OF SOFTWARE, 2022 VS 2030 (%)
• 6. GLOBAL DISEASE-SPECIFIC PATIENT REGISTRY SOFTWARE MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 7. GLOBAL HEALTH SERVICE RESPITE PATIENT REGISTRY SOFTWARE MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 8. GLOBAL PRODUCT RESPITE PATIENT REGISTRY SOFTWARE MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 9. GLOBAL PATIENT REGISTRY SOFTWARE MARKET SHARE BY DEPLOYMENT, 2022 VS 2030 (%)
• 10. GLOBAL PATIENT REGISTRY SOFTWARE BASED ON-PREMISES RESEARCH MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 11. GLOBAL PATIENT REGISTRY SOFTWARE BASED ON CLOUD REVIEW AND MANAGEMENT MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 12. GLOBAL PATIENT REGISTRY SOFTWARE MARKET SHARE BY END-USER, 2022 VS 2030 (%)
• 13. GLOBAL PATIENT REGISTRY SOFTWARE FOR HOSPITALS AND HEALTH SYSTEMS MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 14. GLOBAL PATIENT REGISTRY SOFTWARE FOR GOVERNMENT ORGANIZATIONS AND THIRD PARTY ADMINISTRATORS MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 15. GLOBAL PATIENT REGISTRY SOFTWARE FOR PHARMACEUTICAL, BIOTECHNOLOGY, AND MEDICAL DEVICE COMPANIES MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 16. GLOBAL PATIENT REGISTRY SOFTWARE FOR OTHERS MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 17. GLOBAL PATIENT REGISTRY SOFTWARE MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 18. US PATIENT REGISTRY SOFTWARE MARKET SIZE, 2022-2030 ($ MILLION)
• 19. CANADA PATIENT REGISTRY SOFTWARE MARKET SIZE, 2022-2030 ($ MILLION)
• 20. UK PATIENT REGISTRY SOFTWARE MARKET SIZE, 2022-2030 ($ MILLION)
• 21. FRANCE PATIENT REGISTRY SOFTWARE MARKET SIZE, 2022-2030 ($ MILLION)
• 22. GERMANY PATIENT REGISTRY SOFTWARE MARKET SIZE, 2022-2030 ($ MILLION)
• 23. ITALY PATIENT REGISTRY SOFTWARE MARKET SIZE, 2022-2030 ($ MILLION)
• 24. SPAIN PATIENT REGISTRY SOFTWARE MARKET SIZE, 2022-2030 ($ MILLION)
• 25. REST OF EUROPE PATIENT REGISTRY SOFTWARE MARKET SIZE, 2022-2030 ($ MILLION)
• 26. INDIA PATIENT REGISTRY SOFTWARE MARKET SIZE, 2022-2030 ($ MILLION)
• 27. CHINA PATIENT REGISTRY SOFTWARE MARKET SIZE, 2022-2030 ($ MILLION)
• 28. JAPAN PATIENT REGISTRY SOFTWARE MARKET SIZE, 2022-2030 ($ MILLION)
• 29. SOUTH KOREA PATIENT REGISTRY SOFTWARE MARKET SIZE, 2022-2030 ($ MILLION)
• 30. REST OF ASIA-PACIFIC PATIENT REGISTRY SOFTWARE MARKET SIZE, 2022-2030 ($ MILLION)
• 31. REST OF THE WORLD PATIENT REGISTRY SOFTWARE MARKET SIZE, 2022-2030 ($ MILLION)

Global Patient Registry Software Market Size, Share & Trends Analysis Report by Type of Registry (Disease-Specific Registries, Health Service Registries, and Product Registries), by Type of Software (Stand-Alone Software, and Integrated Software), by Deployment (On-Premises, and Cloud), and by End-User (Hospitals and Health Systems, Government Organizations, and Third Party Administrators (TPAs), Pharmaceutical, Biotechnology, and Medical Device Companies, and Others) Forecast Period (2023-2030)

The global patient registry software market is anticipated to grow at a CAGR of 8.6% during the forecast period (2023-2030). The market's growth is attributed to patient-centered care across the globe. The inclusion of patient-reported outcome measures, in addition to the participation of patient advocacy groups, reflects an increasing tendency toward patient-centered care. This transition is aided by patient registry software, that captures patient viewpoints and experiences. According to the National Institute of Health, in May 2023,patient registries covered a wide range of disease areas, with a focus on Europe. 92% of the registries included clinical patients, 81% obtained informed consent, and 76% protected the collected data. 57% of the registries collected patient-reported outcome measures, 38% consulted PAGs during the registry design process, 51% reported quality management details, and 46% reported maintenance details.

Segmental Outlook

The global patient registry software market is segmented on the type of registry, type of software, deployment, and end user. Based on the type of registry, the market is sub-segmented into disease-specific registries, health service registries, and product registries. Based on the type of software, the market is sub-segmented into stand-alone software, and integrated software. Based on the deployment, the market is sub-segmented into on-premises, and cloud. Further, on the basis of end-user, the market is sub-segmented into hospitals and health systems, government organizations and third-party administrators (TPAs), pharmaceutical, biotechnology, and medical device companies, and others. The government organizations and third party administrators (TPAs) subcategory is expected to capture a significant portion of the market share within the end-user segment. This is attributed to the number of pharmaceutical, biotechnology, and medical device companies has increased, owing essentially to increased demand for pharmaceutical and biotechnology products.

The Disease-specific Registries Sub-Segment is Anticipated to Hold a Considerable Share of the Global Patient Registry Software Market

Among the type of registry, the disease-specific registries sub-segment is expected to hold a considerable share of the global patient registry software market. According to the BMC, in April 2022, a disease registry system is an information system used for collecting, analyzing, and reporting data about a certain population of patients with the same condition. It can be used for healthcare evaluation, estimation of incidence and prevalence, monitoring the quality of care, providing feedback, observing the natural course of diseases, monitoring clinical safety, and assessing disease burden, health outcomes, and costs.

Regional Outlook

The global patient registry software market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, North America is anticipated to hold a prominent share of the market across the globe, owing to the significant prevalence of chronic diseases, in addition to an increase in the number of therapeutic operations conducted in the region.

The Europe Region is Expected to Grow at a Significant CAGR in the Global Patient Registry Software Market

Among all regions, the Europe regions is anticipated to grow at a considerable CAGR over the forecast period. Regional growth is attributed to the rising rare disease advocacy in the region. The growing emphasis on rare disease advocacy and awareness has highlighted to light the unmet medical requirements of patients suffering from orphan diseases. Patient registries help to accomplish these objectives by collecting real-world data on patient experiences. According to the Frontiers, in August 2022, 26.8% of all the marketing authorization applications assessed by the European Medicines Agency (EMA) were for so-called orphan medicinal products, that are meant to treat, prevent or facilitate diagnosis of diseases that are life-threatening or chronically debilitating, but have a prevalence of less than 5 in 10,000 in the European Union (EU). These medicines are often subject to limited clinical evidence owing to their small and heterogeneous patient populations, and patient registries have been identified as a potential way to address this challenge and provide data to support regulatory decision-making. A patient registry is an organized system that collects and organizes data on specified health outcomes for a population with a certain disease, condition or exposure.

Market Players Outlook

The major companies serving the global patient registry software market include Dacima Software, Inc., DSG, Inc., FIGmd Inc., Global Vision Technologies Image Trend Inc., LexisNexis group, IBM Corp., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in April 2022, Quantori, LLC, launched a Registry Science Practice. That focused on the development of registry programs for patients, physicians, and researchers. Registry Science is an emerging area of medical informatics and biostatistics that combines medicine and epidemiology to track long-term health outcomes and improve evidence-based care delivery.

The Report Covers:

• Market value data analysis of 2022 and forecast to 2030.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the global patient registry software market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies. Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

• Current Industry Analysis and Growth Potential Outlook
• 1.1. Research Methods and Tools
• 1.2. Market Breakdown
  • 1.2.1. By Segments
  • 1.2.2. By Region

2. Market Overview and Insights

• 2.1. Scope of the Report
• 2.2. Analyst Insight & Current Market Trends
  • 2.2.1. Key Findings
  • 2.2.2. Recommendations
  • 2.2.3. Conclusion

3. Competitive Landscape

• 3.1. Key Company Analysis
• 3.2. Apixo, Inc.
  • 3.2.1. Overview
  • 3.2.2. Financial Analysis
  • 3.2.3. SWOT Analysis
  • 3.2.4. Recent Developments
• 3.3. ArborMetrix
  • 3.3.1. Overview
  • 3.3.2. Financial Analysis
  • 3.3.3. SWOT Analysis
  • 3.3.4. Recent Developments
• 3.4. Cerner Corp.
  • 3.4.1. Overview
  • 3.4.2. Financial Analysis
  • 3.4.3. SWOT Analysis
  • 3.4.4. Recent Developments
• 3.5. Key Strategy Analysis

4. Market Segmentation

• 4.1. Global Patient Registry Software Market by Type of Registry
  • 4.1.1. Disease-specific Registries
  • 4.1.2. Health Service Registries
  • 4.1.3. Product Registries
• 4.2. Global Patient Registry Software Market by Type of Software
  • 4.2.1. Stand-alone Software
  • 4.2.2. Integrated Software
• 4.3. Global Patient Registry Software Market by Deployment
  • 4.3.1. On-Premises
  • 4.3.2. Cloud
• 4.4. Global Patient Registry Software Market by End-User
  • 4.4.1. Hospitals and Health Systems
  • 4.4.2. Government Organizations and Third Party Administrators (TPAs)
  • 4.4.3. Pharmaceutical, Biotechnology, and Medical Device Companies
  • 4.4.4. Others (Academic and Research Institutions, and Health Insurance Providers)

5. Regional Analysis

• 5.1. North America
  • 5.1.1. United States
  • 5.1.2. Canada
• 5.2. Europe
  • 5.2.1. UK
  • 5.2.2. Germany
  • 5.2.3. Italy
  • 5.2.4. Spain
  • 5.2.5. France
  • 5.2.6. Rest of Europe
• 5.3. Asia-Pacific
  • 5.3.1. China
  • 5.3.2. India
  • 5.3.3. Japan
  • 5.3.4. South Korea
  • 5.3.5. Rest of Asia-Pacific
• 5.4. Rest of the World

6. Company Profiles

• 6.1. Dacima Software, Inc.
• 6.2. DSG, Inc.
• 6.3. FIGmd Inc.
• 6.4. Global Vision TechnologiesImage Trend Inc.
• 6.5. Health Catalyst
• 6.6. IBM Corp.
• 6.7. IQVIA Inc.
• 6.8. Liaison Technology Group
• 6.9. McKesson Corp.
• 6.10. Open Text Corp.
• 6.11. Optum, Inc.
• 6.12. Ordinal Data, Inc.
• 6.13. Syneos Health
• 6.14. Velos Inc.